Radiographic progression-free survival as a surrogate endpoint for overall survival in first-line ARPi naïve metastatic castration-resistant prostate cancer.
- DOI
- 10.1093/oncolo/oyaf425
- Published
- 2026 Jan 17
- Container
- The oncologist
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/oncolo/oyaf425,
title = {Radiographic progression-free survival as a surrogate endpoint for overall survival in first-line ARPi naïve metastatic castration-resistant prostate cancer.},
author = {Castro E and Paganelli S and Wang D and Haltner A and Niyazov A and Chang J and Samjoo IA and Barata PC},
year = {2026},
journal = {The oncologist},
doi = {10.1093/oncolo/oyaf425},
url = {https://doi.org/10.1093/oncolo/oyaf425}
}RIS
TY - JOUR TI - Radiographic progression-free survival as a surrogate endpoint for overall survival in first-line ARPi naïve metastatic castration-resistant prostate cancer. AU - Castro E AU - Paganelli S AU - Wang D AU - Haltner A AU - Niyazov A AU - Chang J AU - Samjoo IA AU - Barata PC PY - 2026 JO - The oncologist DO - 10.1093/oncolo/oyaf425 UR - https://doi.org/10.1093/oncolo/oyaf425 ER -
APA
E, C., S, P., D, W., A, H., A, N., J, C., IA, S., & PC, B. (2026). Radiographic progression-free survival as a surrogate endpoint for overall survival in first-line ARPi naïve metastatic castration-resistant prostate cancer.. The oncologist. https://doi.org/10.1093/oncolo/oyaf425
Source records
- pubmed · retrieved 2026-09-26T17:40:50.016Z